Shows / EHA Unplugged
EHA Unplugged
In these EHA-produced podcasts, experts share with you their hematology knowledge and stories. With "EHA Unplugged" we would like to give you the opportunity to unplug from your computer screen, while still learning, by listening to interviews, clinical cases, monologues, and more.
Episodes
EHA UnpluggedLymphoma - Dr Umut Yilmaz
In this episode, we talk to Dr. Umut Yilmaz from İstanbul University-Cerrahpaşa. Umut shares his interest in lymphoma, its diversity, and the challenges in his…
EHA UnpluggedHow to Get Started in Hematology Research - Dr Anastasia Conti, Assoc Prof Maria Paola Martelli and Dr Simona Valletta
Our guests Dr Anastasia Conti, Assoc Prof Maria Paola Martelli and Dr Simona Valletta give an overview on starting research in hematology. They go through…
EHA UnpluggedPediatric Hematology - Dr Mirjam Belderbos
Listen as guest Dr Mirjam Belderbos talk to our host Prof Kirsten Grønbæk about her own experience in pediatric hematology, how she interacts with her patients…
EHA UnpluggedIron metabolism: physiology and pathology
This week, we have guest Prof Laura Silvestri from Vita-Salute San Raffaele University who gives an amazing overview of iron regulation from the perspective of…
EHA UnpluggedPathogenesis and Management of Acute Chest Syndrome (ACS) in SCD
In this episode, Prof David Rees gives an overview of acute chest syndrome (ACS) in SCD. Prof Rees and host Dr Enrica Orsini talk about epidemiology, the…
EHA UnpluggedEHA Unplugged: MDS Classification and Risk Assessment
In this episode, Prof Maria Teressa Voso talks about MDS classification and risk assessment. She explains the different risk scores, the importance of…
EHA UnpluggedNew Treatment of Iron Metabolism Defects: A Focus on Anemia of Inflammation
Listen as our guest Prof. Martina Muckenthaler and host Dr. Isabel Olivera Martinez give an overview on anemia of inflammation. They discuss the pathogenesis…
EHA UnpluggedLatest Innovations and Future Perspectives in CAR-T Therapy
Listen as Dr. Maria Themeli and Dr. Ciprian Tomuleasa provide an overview of the latest developments and novel ideas in CAR-T therapy. This podcast episode is…
EHA UnpluggedCurrent CAR-T Treatment for Lymphomas Focusing on DLBCL
Listen as Dr. Anna Sureda explains the available CAR-T treatments for lymphomas, focusing on DLBCL (diffuse large B cell lymphoma) and the challenges of CAR-T…
EHA UnpluggedClinical Management of CAR-T Therapy in Myeloma
In this episode Dr Wilson Lim interviews our guest Prof. Carlos Fernández de Larrea on CAR-T toxicities and how to control or avoid adverse reactions to CAR-T…
EHA UnpluggedChallenges in receiving CAR-T treatment: Patient's perspective
Listen as Dr. Anna Sureda discusses CAR-T therapy from a patients perspective and the steps that physicians can take to help patients overcome the challenges…
EHA UnpluggedPh+ acute lymphoblastic lymphoma and the immune system in hematological neoplasms.
Listen as Emeritus Prof Robin Foà brings you on the journey of Ph+ ALL management together with our host Dr Enrica Orsini. With a long career in ALL, Prof Foà…
EHA UnpluggedCAR-T Treatment in Myeloma: State of the Art
Join us for another episode of EHA Unplugged. We have Prof. Herman Einsele here talking about the current landscapes of CAR-T therapy in myeloma, results…
EHA UnpluggedReasons for Failure and Relapse and Mechanisms of Resistance in CAR-T
Join us here at EHA Unplugged with another episode on CAR-T updates. Listen as our guest Prof. Chiara Bonini and host Dr. Wilson Lim discuss the reasons for…
EHA UnpluggedEconomic Aspects of CAR-T: Challenges and Solutions
Listen as Prof. Christian Chabannon provides an overview of the challenges and obstacles raised by the economic aspects of CAR-T treatment. He examines…
EHA UnpluggedUpdate on CAR-T Therapies in Acute and Chronic Leukemias
Listen as Prof. John Gribben provides an update on where we are with CAR-T in acute and chronic leukemias. This podcast episode is part of our FREE course on…
EHA UnpluggedSpotlight Talks: How I Treat Absolute Iron Deficiency in Inflammatory Disorders
Prof Günter Weiss, from the University of Innsbruck, Germany, provides in this podcast a comprehensive pathogenetic and clinical overview of a relevant and…
EHA UnpluggedOverview of the Current CAR-T Landscape
Listen as Prof. Carl June provides an overview of the past and current landscape and challenges in CAR-T therapy, along with a summary of the innovations being…
EHA UnpluggedPapers Unplugged: Precision Medicine and Myeloid Neoplasms
In this podcast, Hartmut Döhner, Hematologist-Oncologist and Professor of Medicine in Germany, discusses with Dr. Nathalie van Havre the role of genomic…
EHA UnpluggedDebate: Gene Addition or Gene Editing for Hemoglobinopathies?
In this podcast about gene therapy for hemoglobinopathies, our experts Dr. Evangelia Yanaki and Professor Franco Locatelli discuss the most effective approach…
EHA UnpluggedWhat's in Store for Lymphoid Malignancies?
In this episode, guest Prof Martin Dreyling and host Dr Nathalie van Havre discuss the latest developments in lymphoid malignancies and the research roadmap…
EHA UnpluggedSpotlight Talks: Postpartum Hemorrhage (PPH)
In this episode of EHA Unplugged, Prof Beverly Hunt discusses the global consequences of postpartum hemorrhage (PPH) and the unacceptable PPH-related mortality…
EHA UnpluggedPapers Unplugged: The Perspectives of Doctors and Patients in the Treatment of CLL
Join Prof Paolo Ghia and our host Dr Enrica Orsini as they discuss the treatment of Chronic Lymphocytic Leukemia (CLL) from the perspectives of patients and…
EHA UnpluggedPapers Unplugged: Precision Medicine in AML
In this podcast, hear from Prof Hartmut Döhner, Hematologist-Oncologist and Professor of Medicine in Germany, as he discusses the growing roles of precise…
EHA UnpluggedDebate: Should Low Risk PV-MF Patients be Treated?
Treatment of low-risk patients with polycythemia vera (PV) and myelofibrosis (MF) is still a matter of debate. Although traditionally these patients were…
EHA UnpluggedHealth Technology Assessment (HTA)
Join our guest Dr Martin Kaiser and host Dr Nathalie van Havre, as they talk about Heath Technology Assessment (HTA) in hematology and in Europe’s public…
EHA UnpluggedSpotlight Talks: New Agents for the Treatment of Thalassemia
In this podcast, you will listen to Prof Antonis Kattamis summarizing the last developments in the treatment of patients with thalassemia. While the life…
EHA UnpluggedPapers Unplugged: What's New in the Treatment of CLL?
In this podcast, Prof Paolo Ghia discusses the current treatment landscape of Chronic Lymphocytic Leukemia (CLL), providing a guide for clinicians faced with…
EHA UnpluggedSpotlight Talks: Updates on the Classification of Hematolymphoid Neoplasms—Myelodysplastic Syndromes
In this podcast, Prof Mario Cazzola illustrates the genesis of the new ICC classification of myeloid neoplasms, published in 2022 (Arber DA et al, Blood 2022)…
EHA UnpluggedPapers Unplugged: TIF Guidelines for the Management of Patients with Transfusion-Dependent Thalassemia (TDT)
What are the latest guidelines for the management of patients with Transfusion-Dependent Thalassemia (TDT)? In 2022, the fourth edition of the TIF (Thalassemia…
EHA UnpluggedSpotlight Talks: Updates on the Classification of Hematolymphoid Neoplasms—Lymphoid Diseases
Spotlight Talks: Updates on the Classification of Hematolymphoid Neoplasms: Lymphoid Diseases In this podcast, Prof John Gribben, former President of EHA…
EHA UnpluggedPapers Unplugged: Is CAR-T Economically Sustainable?
Is CAR-T economically sustainable? Join our guest Prof Martin Dreyling and host Dr Nathalie van Havre as they discuss the costs of CAR-T cell therapy for the…
EHA UnpluggedPapers Unplugged: What Ever Happened to Plan S?
What is Plan S and what has happened to it? Join our guest Dr Nuno Borges and host Dr Christian Scharenberg as they talk about the core principles, goals, and…
EHA UnpluggedPapers Unplugged: CHIP and Associated Risk in Elderly Patients
What is clonal hematopoiesis of indeterminate potential (CHIP) and its associated risks in elderly patients? Join our guest Prof Kirsten Gronbaek and host Dr…
EHA UnpluggedPapers Unplugged: EHA and War in Ukraine
What can a not-for-profit NGO do for patients in a time of war? Join our guests, Prof Konstanze Döhner, Prof Elizabeth Macintyre, and Dr Nathalie van Havre as…
EHA UnpluggedPapers Unplugged: Precision Medicine and Hemoglobinopathies
Join our guest Prof David Rees and host Dr Christian Scharenberg as they discuss how the concept of precision medicine can be applied to Sickle Cell Disease…
EHA UnpluggedNaive CLL
How did CLL lose its role of "Cinderella" in hematology in the last decades, thanks to the introduction of entirely new classes of drugs, and came under the…
EHA UnpluggedThrombosis - Bleeding in Cancer
The links between thrombosis and cancer have been known for a long time and are associated with the type of cancer (pancreatic and lung carcinomas, for…
EHA UnpluggedThe Microbiome in HCT
In this podcast, Prof Tessa Andermann, an expert in infectious diseases, provides an overview of the role of the microbiome in the homeostasis of the human…
EHA UnpluggedDiagnosing Erythrocytosis
How do you make a diagnosis of erythrocytosis? Is full blood count enough or do you need more specific tests? How is the classification in primary and…
EHA UnpluggedClinical Trials of the Future (Clinical Trial)
In the seventh and final episode of the Clinical Trial podcast series, you can hear Prof. Konstanze Döhner and Prof. Antonio Almeida exchanging ideas and…
EHA UnpluggedCutaneous T Cell Lymphoma (CTCL) Episode 1: Presentation and Diagnosis
This series of two podcasts leads you on a journey through the main clinical and therapeutical aspects of Cutaneous T Cell Lymphomas (CTCLs), a heterogeneous…
EHA UnpluggedCutaneous T Cell Lymphoma (CTCL) Episode 2: Treatment
This series of two podcasts leads you on a journey through the main clinical and therapeutical aspects of Cutaneous T Cell Lymphomas (CTCLs), a heterogeneous…
EHA UnpluggedCirculating Tumor DNA
Dr David Kurtz discusses in this podcast the most recent technical developments and practical applications of circulating tumor DNA and liquid biopsies, an…
EHA UnpluggedTreating CML in Developing Countries
The whole world of CML changed in the early 2000s with the introduction of imatinib and TKIs, however, the situation in developing countries can be…
EHA UnpluggedLess is More - Transfusion
Transfusion processes have changed significantly in recent years, at the same time changing the guidelines for blood cell replacement therapy. Listen to Prof…
EHA UnpluggedChronic Myeloid Leukemia (Naomi)
This podcast follows a short discussion between two young hematologists on a clinical case review of a chronic myeloid leukemia patient called Naomi. In this…
EHA UnpluggedAll Good Things Must Come to an End: How and When to End a Clinical Trial (Clinical Trial)
In the sixth episode of the Clinical Trial podcast series, Prof. Robert Hills discusses the different reasons that lead to the end of a trial – especially when…
EHA UnpluggedIron Deficiency: Perioperative
In the fourth episode of the EHA Diagnosing And Treating Iron Deficiency podcast series, host Prof Gunnar Birgegård and guest expert Prof Antonio Almeda…
EHA UnpluggedDocumentation and authorization: Safeguarding the Credibility of Clinical Trials (Clinical Trial)
In the fifth episode of the Clinical Trial podcast series, Prof. Robert Hills discusses the documentation of clinical trials and how it represents a safeguard…
EHA UnpluggedEthical Issues Associated with Treating Hematological Malignancies in Older Adults (Aging Patient: Dispelling Myths)
In the fifth and final episode of the Aging Patient: Dispelling Myths podcast series, host Gareth Tucker and guest experts Prof Raul Cordoba, Dr Ulrich…
EHA UnpluggedSponsor: A Role to Take Seriously (Clinical Trial)
In the fourth episode of the Clinical Trial podcasts, Dr. Eleftheria Hatzimichael gives us an overview of the sponsor's role and responsibilities in…
EHA UnpluggedHematological Changes in Older Adults (Aging Patient: Dispelling Myths)
In the fourth episode of the Aging Patient: Dispelling Myths podcast series, host Gareth Tucker and guest expert Prof Monica Engelhardt discuss how…
EHA UnpluggedPatient Support: Relate and Create (Clinical Trial)
In the third episode of the Clinical Trial podcasts, Prof. Martin Dreyling from the University of Munich makes several points about standards of care in…
EHA UnpluggedTreatment of Hematological Malignancies in Older Adults (Aging Patient: Dispelling Myths)
In the third episode of the Aging Patient: Dispelling Myths podcast series, host Gareth Tucker and experts Prof Antonio Almeida, Prof Valentin Goede, and Dr…
EHA UnpluggedThe Paper Trail (CRO) (Clinical Trial)
In the second episode of the Clinical Trial podcasts, former EHA President Prof. John Gribben gives us an overview of the role(s) of CROs (Contract Research…
EHA UnpluggedPatient Assessment In Older Adults (Aging Patient: Dispelling Myths)
In the second episode of the Aging Patient: Dispelling Myths podcast series, host Gareth Tucker discusses with experts Prof Alessandra Tucci and Prof Sergio…
EHA UnpluggedMultiple Myeloma in Underserved Populations (Episode 3)
In this podcast, the last of a series dedicated to Multiple Myeloma in underserved patient populations with, Prof Sonja Zweegman focuses on the challenges…
EHA UnpluggedWhat matters in a trial design? (Clinical Trial)
In the first episode of the Clinical Trial podcasts, Amsterdam UMC researcher and author of “A Quick Guide on How to Conduct Medical Research” Dr. Marieke Ter…
EHA UnpluggedAging and Clonal Diseases (Aging Patient: Dispelling Myths)
In the Aging Patient: Dispelling Myths podcast series, Prof Raul Cordoba kicks off a series of podcasts that will offer you up-to-date information about…